Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T16:28:10.354Z.
Calculation as of: 2026-10-06T16:28:10.354Z.
Quote observation: 2026-10-06T16:24:59.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e005637c0728ee7719d987fd9d1ed1bb4b4a72c9577e4c0c1fad472fb0ddb1d0
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Outset Medical, Inc.
Market Cap
$76.00M
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| Outset Medical, Inc. (OM) | $76.00M | N/A |
| SkinHealth Systems Inc. (SKIN)vs › | $75.91M | N/A |
| Hyperfine, Inc. (HYPR)vs › | $75.49M | N/A |
| Pulmonx Corporation (LUNG)vs › | $78.14M | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $78.57M | N/A |
| Gain Therapeutics, Inc. (GANX)vs › | $72.51M | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.46M | N/A |
| Sera Prognostics, Inc. (SERA)vs › | $79.82M | N/A |
| MindWalk Holdings Corp. (HYFT)vs › | $70.48M | N/A |
| Nutriband Inc. (NTRB)vs › | $82.07M | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
